21 Articles found The Importance of Clinical Trials The Search For A Cause of MS MS and Autoimmune Thyroiditis Making Sense of MS Research (Transcript) The Genetic Connection Shades of Gray: MS Misconceptions, Misunderstandings, and Misinterpretations 15 Years of MS Therapy What About the Side Effects? Oral Medications for MS Treatment The Potential Role of Chemokines in Remyelination The Medication Solution Assists in Restoring Emotional Health Fampridine SR - One Step Closer to Becoming a Reality Exploring Our Differences: African Americans and MS When Medication Stops Working or Causes Complications: It's Time to Switch The Changing Face of MS Examining the Ampyra™Experience By: Daniel Kantor, M.D. Emergies Therapies Teleconference with Dr. Aaron Boster LDN: Miracle or Myth? The Next Chapter in MS Care Prescription Pain Relief What to Expect from Your MS Disease-Modifying Drug
59 News found 05/06/2013 MS Risk Appears to be Higher for African Americans than Caucasians 03/27/2013 Oral Medication Tecfidera™ Approved for Relapsing MS 03/21/2013 Breaking News from AAN 65th Annual Meeting 01/24/2013 Injectable Drug Demonstrates Efficacy with Reduced Dosing Schedule 01/04/2013 Rebif Single-Use Auto-Injector Approved 11/19/2012 Re-Educating Immune Cells May Halt MS Progression 11/05/2012 Blocking Enzyme May Allow Remylination 09/21/2012 Latest BG-12 Trial Results Show Significant Benefit 09/13/2012 Another Oral Medication Approved for Relapsing MS 07/18/2012 Interferon Beta May not Slow MS Progression According to New Study 06/18/2012 Study Identifies Gene Linked to Vitamin D Deficiency 06/14/2012 Fertility Treatment Tied to Higher Relapse Rate in Women with MS 06/13/2012 Another MS Drug Application Submitted for FDA Approval 06/12/2012 Video Coverage of the European Neurological Society 2012 Meeting 05/10/2012 FDA Alerts on Potential Dangers of “Liberation Therapy” for CCSVI 04/24/2012 Novartis Updates U.S. Label on Gilenya® 04/16/2012 Gilenya® Role in PML Diagnosis Unclear 03/08/2012 Pregnancy May Cut Risk of Developing MS 02/28/2012 BG-12 New Drug Application Submitted 01/20/2012 European Medicines Agency Strengthens Gilenya Guidelines While Review Underway 12/12/2011 Investigation Underway into Death of Gilenya Patient 12/09/2011 Genetic Clue to MS Identified 12/08/2011 Brain Biopsies Yield Clues to MS Course 10/31/2011 Friendly Gut Bacteria May Play Role in Triggering MS 10/26/2011 BG-12 Moves Forward with Positive Data from Late-Stage Trials 10/18/2011 Circadian Disruption may Contribute to MS Development in Youth 08/17/2011 Research Identifies How Vitamin D Combats MS 08/16/2011 Anti-Inflammatory Agents Silence Overactive Immune Response 08/11/2011 Number of Genes Linked to MS More than Doubles 06/10/2011 Study Suggests Shingles Nearly Quadruples MS Risk in Asia 06/08/2011 Research Examines Cellular Events that May Lead to MS 05/19/2011 Estrogen Receptors Play Anti-Inflammatory Role in the Brain 04/27/2011 Blocking Crucial Molecule Could Help Treat Multiple Sclerosis 04/27/2011 Common Virus Plus Low Sunlight Exposure May Increase Risk of Multiple Sclerosis 04/13/2011 Gilenya™ Reduces Risk of MS Disability Progression Regardless of Treatment History 04/13/2011 New Study Results Cast Doubt on Theory that CCSVI Causes MS 04/12/2011 Late-Stage Trial of Oral BG-12 for Relapsing-Remitting MS Shows Postive Results 04/11/2011 Oral Drug for MS Significantly Reduces Disease Activity and Slows Disability in Long-Term Study 03/24/2011 Stem Cells May Show Promise for People with Rapidly Progressing MS 02/24/2011 Warmer Weather Hampers Thinking Skills in People with MS 02/17/2011 Study Results Provide More Clues to Understanding the Pathology of MS 02/11/2011 More evidence that Vitamin D affects MS risk 01/20/2011 Plasma Exchange Effective In Treating Severe MS Relapses 11/24/2010 Toxin and Potential MS Treatment Focus of Research 11/19/2010 Researchers Make Surprising Discovery While Testing MS Pain Remedy 09/22/2010 First Oral Treatment for MS Approved by FDA 08/04/2010 New Studies Fail to Link CCSVI and MS 07/20/2010 Gut Bacteria and the MS Connection 06/30/2010 Study of “Liberation Treatment” to Launch in Buffalo 06/11/2010 Gilenia Gets Stamp of Approval From Advisory Panel to FDA 06/10/2010 Steroids Reduce Postpartum Relapses in Study 05/03/2010 Biomarkers Test for MS Nine Years Before Symptoms Appear 03/11/2010 FDA Approves Botox to Treat Spasticity in Flexor Muscles of the Elbow, Wrist and Fingers 03/10/2010 Study Implicates Epstein-Barr Virus in Development of MS 02/16/2010 Study Combining Daclizumab with Interferon Beta Treatment Brings Positive Results 02/10/2010 One of First CCSVI Studies Releases Preliminary Results 08/17/2009 Novartis Version of Betaseron to Hit Market This Fall 06/03/2009 Diabetes Drug Shows Potential in Treating MS 06/03/2009 Share Your Health Care Story
No Videos found
14 Audios found Deciding Which Disease Modifiying Therapy is Right for You with Dr. Daniel Kantor - March 5th, 2013 Teleconference. MS Treatments and Symptom Management with Dr. Daniel Kantor - March 13th, 2012 Teleconference Emerging Therapies Teleconference with Dr. Aaron Boster - March 2nd, 2011 Teleconference Emerging Therapies Teleconference with Dr. Aaron Boster - March 3rd, 2011 Teleconference The Medication Solution Assists in Restoring Emotional Health The Changing Face of MS Exploring Our Differences: African Americans and MS When Your Medication Stops Working or Causes Complications: It's Time to Switch Fampridine SR - One Step Closer to Becoming a Reality The Potential Role of Chemokines in Remyelination What About the Side Effects? Shades of Gray: MS Misconceptions, Misunderstandings, and Misinterpretations MS Drugs in the Pipeline Connectivity Among Autoimmune Diseases,Including MS